---
title: National Institutes Of Health
description: 
published: true
date: 2025-09-22T21:16:10.258Z
tags: 
editor: markdown
dateCreated: 2025-09-22T21:16:06.263Z
---

# National Institutes Of Health

### Cardiovascular Diseases Research

**2022: Fitzpatrick Voted To Authorize \$1 Million Annually Through FY
2027 For The National Institutes Of Health To Research Cardiovascular
Diseases Among At-Risk Communities And Create An Online Resource Of
Heart Health Research And Treatment Options.** In July 2022, according
to Congressional Quarterly, Fitzpatrick voted for the South Asian Heart
Health Awareness and Research Act of 2022, which would "authorize \$1
million annually through fiscal 2027 for the National Institutes of
Health to conduct or support research on cardiovascular disease and
related ailments among at-risk populations and to establish an online
clearinghouse of heart health research and treatment options." The vote
was on passage. The House passed the bill by a vote 237-192, thus the
bill was sent to the Senate. The Senate did not take substantive action
on the bill. \[House Vote 398,
[7/27/22](http://clerk.house.gov/evs/2022/roll398.xml); Congressional
Quarterly, [7/27/22](https://plus.cq.com/vote/2022/H/398?16);
Congressional Actions, [H.R.
3771](https://www.congress.gov/bill/117th-congress/house-bill/3771/actions)\]

### Pediatric Research Initiative

**2024: Fitzpatrick Voted To Reauthorize The National Institutes Of
Health Pediatric Research Initiative Through FY 2028.** In March 2024,
Fitzpatrick voted for , according to Congressional Quarterly, "the bill,
as amended, that would reauthorize the Pediatric Research Initiative at
the National Institutes of Health for five years, through fiscal 2028,
at the prior authorization level of \$12.6 million per year.
Authorization for the program expired on Sept. 20, 2023. The bill would
express the sense of Congress that the NIH director should continue to
oversee and coordinate research conducted or supported by the NIH on
pediatric cancer and other pediatric diseases and conditions. It would
also add program language stating that the NIH must prioritize research
that does not duplicate research activities that already exist." The
vote was on passage. The House passed the bill by a vote of 384 to 4.
\[House Vote 60, [3/5/24](http://clerk.house.gov/evs/2024/roll060.xml);
Congressional Quarterly,
[3/5/24](https://plus.cq.com/vote/2024/H/60?39); Congressional Actions,
[H.R.
3391](https://www.congress.gov/bill/118th-congress/house-bill/3391/all-actions)\]